Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center, Houston
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jiujiang University Affiliated Hospital
Washington University School of Medicine
University of Iowa
University of Iowa
Medical University of South Carolina
Vanderbilt University
Children's Oncology Group
Eli Lilly and Company
Northwestern University